Bud Genius Inc (OTCMKTS:RIGH) a leading lab for cannabis testing and profiling, brand and retail development specialist firm, developer of rating systems for pot strains, and licensee of celebrity-supported pot and hemp associated merchandise, said that it is considering share repurchase option of up to 2 billion shares. It may have a chance to purchase shares of its own stock at a good price.
The buyback decision of Bud Genius represents the continued confidence of the company in the growth plans and ability to record new revenues. The company may open the share purchasing in the open market or via privately negotiated transactions, subject to legal requirements, market conditions and other relevant factors.
Addition to advisory board
In other news Bud Genius announced an addition to its executive advisory board. Peter Wilson, Ph.D., a highly respected and well known expert in business law, accounting and financial reporting will be part of the Executive Advisory Board to offer his insight and expertise as the company ventures into its rapid growth phase. He has more than 25 years of experience in field of corporate finance and spent almost nineteen years at Fuqua School of Business where he was one of the accounting faculties. He even served as the Director of “Executive MBA” courses.
Prior to his role at Fuqua, Dr. Wilson imparted learning at the Stern School of Business in the undergraduate and graduate programs. He was the Director of the” Undergraduate Course” in Taxation, Accounting and Business Law. Angel Stanz, the CEO of Bud Genius Inc (OTCMKTS:RIGH) said that the management is delighted to have Dr. Wilson become a part of company’s Executive Advisory Board. As an expert in financial reporting, corporate finance and accounting, Dr. Wilson will offer expertise in several areas that can greatly impact the future of the company. In last trading session, the stock price of closed flat at $0.00020.